Stockreport

Novo Holdings Participates in €90 Million Series A Financing Round for Orbis Medicines to Support Development of Oral Macrocycle Drugs [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Orbis' n Gen platform systematically explores oral macrocycle design with automated chemistry and machine learning Novo Holdings Partner, Morten Graugaard , to lead O [Read more]